Supplementary Figure S4 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966
Tae Jin Lee(Augusta University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Joseph N. Liu(The Ohio State University Wexner Medical Center), Balveen Kaur(Augusta University), Manish K. Aghi(Neurological Surgery), Yeshavanth Banasavadi‐Siddegowda(Neurological Surgery), W. Shawn Carbonell, Haroon Quadri(Northeast Ohio Medical University), Tejaswini Nallanagulagari(The Ohio State University Wexner Medical Center), Kurt H. Bockhorst(The University of Texas Health Science Center at Houston), Alena Cristina Jaime‐Ramirez(The Ohio State University), Jianying Zhang(Shanxi Agricultural University), Jeffrey Yunhua Guo(The Ohio State University), Mitra Nair
Cited by 0
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
|Autophagy|2016|6k
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360
Characterization of differential properties of rabbit tendon stem cells and tenocytes
|BMC Musculoskeletal Disorders|2010|345
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332